- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- October 2023
- 150 Pages
Global
From €4719EUR$4,850USD£4,043GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Report
- January 2024
- 143 Pages
Global
From €4135EUR$4,250USD£3,542GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4816EUR$4,950USD£4,126GBP
- Report
- November 2018
- 164 Pages
Global
From €2286EUR$2,349USD£1,958GBP
- Report
- October 2022
- 95 Pages
Global
From €4669EUR$4,799USD£4,000GBP
- Report
- November 2020
- 136 Pages
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- November 2020
- 155 Pages
Asia Pacific
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- November 2020
- 157 Pages
Europe
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- November 2020
- 164 Pages
Middle East, Africa
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- November 2020
- 142 Pages
North America
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- September 2020
- 215 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- September 2020
- 194 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- July 2022
- 73 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- April 2023
- 190 Pages
Global
From €3405EUR$3,500USD£2,917GBP
- Report
- April 2023
- 246 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- July 2022
- 146 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
The Kidney Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. These drugs are used to treat a variety of conditions, including chronic kidney disease, acute kidney injury, and end-stage renal disease. They can also be used to treat other conditions such as hypertension, diabetes, and anemia. These drugs are typically prescribed by a physician and can be taken orally or intravenously. They can also be administered through dialysis or other treatments.
The Kidney Disease Drug market is highly competitive, with many companies offering a variety of products. These companies include major pharmaceutical companies, as well as smaller, specialized companies. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more